The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease (Q44247540)

1 December 2017

The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease (English)

1 reference

1 December 2017

Joong-Seok Kim

1

1 reference

1 December 2017

Si-Ryung Han

2

1 reference

1 December 2017

Sung-Woo Chung

3

1 reference

1 December 2017

Beum-Saeng Kim

4

1 reference

1 December 2017

Kwang-Soo Lee

5

1 reference

1 December 2017

Yeong-In Kim

6

1 reference

1 December 2017

Dong-Won Yang

7

1 reference

1 December 2017

Kwang-Soo Kim

8

1 reference

1 December 2017

Jong-Won Kim

9

1 reference

1 December 2017

1 January 2003

1 reference

Journal of the Neurological Sciences

1 December 2017

1 reference

1 December 2017

206

1 reference

1 December 2017

1

1 reference

1 December 2017

31-37

1 reference

Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Long-term risk of first recurrent stroke in the Perth Community Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Meta-analysis of relation between cigarette smoking and stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Familial aggregation of stroke. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

The importance of family history in cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E epsilon 2 allele and risk of stroke in the older population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E genotyping by one-stage PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

The effects of APOE genotype on age at onset and progression of neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Cardiovascular risk factors in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900361-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00361-1

1 reference

1 December 2017

1 reference